Clinical trial Recruiting at 1 site Interventional Ages 50 and up

Slow-SPEED: Can a smartphone app help people with prodromal Parkinson's stay more active?

Official title: Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

Run by Radboud University Medical Center · NCT06993142 · Data updated 2026-11-12

This trial tests whether a remote smartphone app can help people with a LRRK2 G2019S or GBA1 N370S mutation increase daily activity and see if exercise might slow prodromal Parkinson's signs.

Quick facts

Study typeInterventional
Ages50 Years and up
SexAll
Enrollment600 (estimated)
SponsorRadboud University Medical Center
Academic / other
Locations2 sites (Rochester, New York and 1 other locations)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedJune 30, 2029
Study endsJune 30, 2029
Registry record updatedOctober 15, 2026
Trial IDNCT06993142 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 50 years or older with a confirmed LRRK2 G2019S or GBA1 N370S mutation who can walk indoors, use a compatible smartphone, and are not highly physically active at baseline.

Probably not a fit

Individuals without the specified genetic mutations or those unable to engage in long-term smartphone-guided activity may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with LRRK2 G2019S or GBA1 N370S mutations will use a mobile app to gradually increase daily steps and exercise time at a target heart rate over up to 36 months. The study collects digital biomarkers to form a prodromal load score, aiming to gauge changes in motor and non-motor prodromal features. Primary goals include long-term feasibility of remote, app-driven exercise and preliminary signals of effect on prodromal progression. The trial is conducted across multiple centers, leveraging a fully remote intervention with in-home activity monitoring. Eligibility requires genetic confirmation, adequate smartphone access, and ability to walk independently indoors.

Why it matters

Potential benefit: If successful, participants could experience increased physical activity with a potentially slower prodromal progression of Parkinson's disease.

How similar studies have gone: Prior studies using remote, app-based activity support have shown feasibility and positive signals for increasing activity, though this exact long-term, prodromal-focused approach is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria

1. previously identified LRRK2 G2019S or GBA N370S variant based on genotyping
2. aged 50 years or older
3. able to understand the English language
4. being able to walk independently inside the home without the use of a walking aid
5. in possession of a suitable smartphone (screen size minimum 4.6 inch), (Android version 9 or iOS version 15 or newer)
6. Not in a high physical activity range during the 4-week eligibility and baseline period

Exclusion criteria

1. clinically diagnosed or self-reported diagnosis neurodegenerative disease
2. self-reported falls of three or more per year
3. dexterity problems or cognitive impairments hampering smartphone use
4. if they are not aware of and do not wish to be informed about an increased risk of developing diseases associated with the LRRK2 or GBA1 risk variant
5. if individual is not community-dwelling
6. in possession of one of the following devices: Huawei P8 Lite; Huawei P9 Lite; Xiaomi Mi 6; Huawei P20 Lite (Fitbit is incompatible)

Where it's running

  • University of Rochester Center for Health and Technology (CHeT)
    Rochester, New York, United States
    Recruiting
  • Radboud University Medical Center
    Nijmegen, Gelderland, Netherlands
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.